Autres langues IRIDEX Corporation

Actions

IRIX

US4626841013

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2026			Varia. 5j.	Varia. 1 janv.
0,9344 ^USD	-1,75%		-15,05%	-18,04%

13/07	Novel Inspiration International Co Ltd entend engager le dialogue avec IRIDEX Corporation	CI
19/05	Transcript : IRIDEX Corporation, Q1 2026 Earnings Call, May 19, 2026

Autres langues

13/07	Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation
09/06	Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
19/05	IRIDEX : Quarterly Report for Quarter Ending April 4, 2026 (Form 10-Q)
19/05	IRIDEX Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026
19/05	Iridex: Q1 Earnings Snapshot
19/05	Iridex Reports First Quarter 2026 Financial Results
19/05	IRIDEX Corporation Reaffirms Earnings Guidance for the Full Year 2026
05/05	Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
07/04	Iridex, EyeProGPO Partner to Offer Preferred Pricing on Retina Laser Technology
07/04	Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
07/04	Iridex Announces New Partnership with Eyeprogpo to Expand Member Access to Retina Laser Technology
02/04	IRIDEX : Annual Report for Fiscal Year Ending January 3, 2026 (Form 10-K)
26/03	Iridex: Q4 Earnings Snapshot
26/03	IRIDEX Fiscal Q4 Loss Narrows, Revenue Rises; 2026 Guidance Set
26/03	Iridex Reports Fourth Quarter and Full Year 2025 Financial Results
26/03	IRIDEX Corporation Provides Earnings Guidance for the Year 2026
26/03	IRIDEX Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended January 03, 2026
12/03	Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
02/02	Iridex Announces Plans to Relocate Headquarters
02/02	Iridex Announces Plans to Relocate Headquarters
02/02	Iridex Corporation Plans to Relocate its Headquarters
12/01	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
12/01	IRIDEX Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025
08/01	Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation
11/12	Iridex Corporation Announces the Publication of an Independent Study Demonstrating Safe and Effective Ret Treatment with Transcleral Laser Treatment Using Micropulse®? Technology in Glaucoma Management